Literature DB >> 22033191

The discovery and early understanding of leukemia.

Kim R Kampen1.   

Abstract

The early history of leukemia reaches back 200 years. In 1811, Peter Cullen defined a case of splenitis acutus with unexplainable milky blood. Alfred Velpeau defined the leukemia associated symptoms, and observed pus in the blood vessels (1825). Alfred Donné detected a maturation arrest of the white blood cells (1844). John Bennett named the disease leucocythemia, based on the microscopic accumulation of purulent leucocytes (1845). That same year, Rudolf Virchow defined a reversed white and red blood cell balance. He introduced the disease as leukämie in 1847. Henry Fuller performed the first microscopic diagnose of a leukemic patient during life (1846). This gradual process brought us towards our current understanding of this complex disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22033191     DOI: 10.1016/j.leukres.2011.09.028

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  12 in total

Review 1.  Frontline treatment of acute myeloid leukemia in adults.

Authors:  Gevorg Tamamyan; Tapan Kadia; Farhad Ravandi; Gautam Borthakur; Jorge Cortes; Elias Jabbour; Naval Daver; Maro Ohanian; Hagop Kantarjian; Marina Konopleva
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-11       Impact factor: 6.312

Review 2.  Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.

Authors:  Krishna V Komanduri; Ross L Levine
Journal:  Annu Rev Med       Date:  2015-10-16       Impact factor: 13.739

3.  Cordycepin enhances hyperthermia-induced apoptosis and cell cycle arrest by modulating the MAPK pathway in human lymphoma U937 cells.

Authors:  Liying Shi; He Cao; Siyu Fu; Zixian Jia; Xuan Lu; Zhengguo Cui; Dayong Yu
Journal:  Mol Biol Rep       Date:  2022-06-28       Impact factor: 2.742

Review 4.  How is the Ph-like signature being incorporated into ALL therapy?

Authors:  Luke Maese; Sarah K Tasian; Elizabeth A Raetz
Journal:  Best Pract Res Clin Haematol       Date:  2017-06-15       Impact factor: 3.020

Review 5.  Novel Treatment Paradigms in Acute Myeloid Leukemia.

Authors:  Nabin Khanal; Shristi Upadhyay Banskota; Vijaya Raj Bhatt
Journal:  Clin Pharmacol Ther       Date:  2020-08-11       Impact factor: 6.903

6.  Driving forces behind the past and future emergence of personalized medicine.

Authors:  Julius Alexander Steffen; Jan Simon Steffen
Journal:  J Pers Med       Date:  2013-01-17

7.  Leukemia-Related Mortality in Inner Mongolia, 2008-2012.

Authors:  Zhihui Hao; Yongsheng Chen; Yongjun Xu; Maolin Du; Ying Wang; Qing Zhang; Heixiao Bai; Sun Juan
Journal:  Glob J Health Sci       Date:  2015-11-18

Review 8.  Colliding Epidemics and the Rise of Cryptococcosis.

Authors:  Christina C Chang; Sharon C-A Chen
Journal:  J Fungi (Basel)       Date:  2015-12-23

9.  Precision medicine: the foundation of future cancer therapeutics.

Authors:  Seung Ho Shin; Ann M Bode; Zigang Dong
Journal:  NPJ Precis Oncol       Date:  2017-04-24

10.  Investigation of effects and mechanisms of total flavonoids of Astragalus and calycosin on human erythroleukemia cells.

Authors:  Dongqing Zhang; Yuan Zhuang; Jichun Pan; Haibao Wang; Hui Li; Yang Yu; Deqing Wang
Journal:  Oxid Med Cell Longev       Date:  2012-06-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.